TXP Medical and Total Future Healthcare Conduct Survey on Bathtub Drowning Cases at Home

TXP Medical Inc. (Representative Director and CEO: Tomohiro Sonoo, hereinafter TXP Medical) and Total Future Healthcare Inc. (Representative Director and Chairman: Tsuneyo Sasaki) conducted a clinical survey on drowning and cardiopulmonary arrest (CPA) cases in bathtubs at homes and nursing care facilities.

The purpose of this survey is to comprehensively understand the processes of occurrence, discovery, and transport in bathtub drowning cases, providing insights for the social implementation of early detection and intervention solutions.

The number of deaths from drowning accidents at home in Japan reached approximately 6,900 in 2023 (*1), amounting to roughly 2.6 times the number of traffic accident deaths (*2). Furthermore, as approximately 90% (*1) of drowning deaths are elderly individuals, this represents a critical challenge in a super-aging society.

In this survey, utilizing medical data collected through TXP Medical's NEXT Stage ER from 195 cases (133 CPA cases and 62 non-CPA cases) at three emergency medical facilities nationwide, we clarified the patient profiles, accident circumstances, time until discovery, emergency call conditions, and outcomes in emergency outpatient departments. The results confirmed that despite the vast majority of cases involving independent elderly individuals living with family members, the enclosed space of the bathroom impedes immediate discovery, resulting in an extremely low post-CPA survival rate of 9.0%.

Through this survey, real clinical data verified the structural issue where 'independent elderly individuals suddenly drown in their home bathtubs, leading to cardiopulmonary arrest due to delayed discovery even while living with family.' Because the survival rate after cardiopulmonary arrest is extremely low (ROSC rate* 9.0%) and there are limits to retrospective resuscitation measures, the findings suggest that the top priority for intervention is 'early detection and drainage prior to cardiopulmonary arrest.'

ROSC rate*: Return of Spontaneous Circulation rate. The percentage of cardiopulmonary arrest (CPA) patients whose heartbeat returned due to resuscitation efforts.

(Sources)

(*1) Ministry of Health, Labour and Welfare, 'Vital Statistics'

(*2) Cabinet Office, 'White Paper on Traffic Safety in Japan 2023'

TXP Medical will continue to visualize medical realities using Real World Data (RWD), supporting medical device manufacturers and pharmaceutical companies in promoting appropriate usage and strategic planning.

[NEXT Stage ER (NSER)]

NEXT Stage ER (NSER) is a patient information recording and management system specialized for emergency outpatient operations in large hospitals, such as critical care centers. Operating on electronic medical record terminals, it comprehensively centralizes and shares patient information entered by multidisciplinary teams including doctors and nurses, supporting rapid and accurate medical care in emergency departments.

Information such as chief complaints, present illness history, vital signs, and treatments can be efficiently recorded and shared in real-time across multiple hospital terminals via an electronic whiteboard function. It also supports on-site decision-making with triage support based on JTAS and automatic calculation features for various medical scores.

These medical records are naturally accumulated during daily operations, resulting in improved efficiency for organizing data required for creating emergency registers and conducting clinical research. As a core system, it has been introduced in over 100 large hospitals nationwide, holding roughly a 50% market share among university hospitals and critical care centers.

https://txpmedical.jp/service/next-stage-er/

[TXP Medical Inc. - Mission: 'Saving lives with medical data']

Structures Real World Data (RWD) derived from electronic medical records based on data utilization agreements concluded with over 50 university and regional core hospitals nationwide.

Covers data of over 25 million patients.

Has built a network of over 50 cooperating facilities centered on 800-bed class large hospitals.

Develops clinical research support, reality survey, and clinical trial support services utilizing over 900 standardized lab values and abundant medical chart text.

Boasts a team of over 40 specialist physicians covering everything from planning to paper writing.

Proven track record of collaboration with over 40 pharmaceutical companies and medical device manufacturers.

Covers all clinical departments, supporting problem-solving across diverse disease areas from acute care to rare diseases and oncology.

Company Name: TXP Medical Inc.

Location: AKIHABARA CENTRAL SQUARE 2F, 3-21-24 Kanda Sakumacho, Chiyoda-ku, Tokyo

Representative: Representative Director and CEO Tomohiro Sonoo (Emergency Medical Specialist)

Established: August 2017

Business Description: Acute care medical data platform, AI technology, RWD utilization services

Related URLs:

- TXP Medical Corporate Site: https://txpmedical.jp/

- TXP Medical Medical Data Division: https://medical-dataservice.txpmedical.jp

- TXP Medical Medical Data Division Service Overview Video: https://www.youtube.com